Brain imaging technology for Swinburne
Date posted: Tuesday 19 Apr 2011
Melbourne’s Swinburne University of Technology is set to become a national hub for neuroscience, after the acquisition of two state-of-the-art brain imaging machines.
The university has just purchased Victoria’s first magnetoencephalograph (MEG) machine from Elekta, made possible thanks to a $1.55 million dollar grant announced last year by the federal government under the Education Investment Fund.
MEG, a non-invasive technique that measures magnetic fields generated by the brain’s activity, is one of the most advanced tests of brain function in the world.
According to Professor Mike Kyrios, Director of Swinburne’s Brain and Psychological Sciences Research Centre, the presence of a MEG machine at the university will have a significant impact on its basic and clinical research capabilities.
“With MEG you can localise and map where brain activity is happening and you can do that in real-time – from moment to moment – within millisecond resolution. This will allow us to detect brain activity much more accurately and in more detail than ever before,” he said.
“As a result we will be able to pursue advanced neuroscience research, search for clues to cognitive and mental health disorders and gain a much more thorough understanding of brain function.”
According to Professor Kyrios the MEG machine, due to arrive mid year, will complement the university’s recent acquisition of a Magnetic Resonance Imaging (MRI) machine from Siemens. Delivered earlier this month, the MRI machine will also be used to visualise detailed internal brain structures and functions.
These machines will join Swinburne’s existing neuroscience technology including Electroencephalography (EEG) and Transcranial Magnetic Stimulation (TMS) capabilities.
A Victorian Science Agenda Grant announced last year will also support new staff positions within the Swinburne neuroscience facility.
As the only facility in Australia to operate all of these machines, Swinburne’s Brain and Psychological Sciences Research Centre will be well placed to make significant clinical and research advances in the neuroscience field.